BioNxt Solutions Inc. (BNXT.CN)
CAD 0.32
(1.61%)
CAD 0.32
(1.61%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.08 CAD | 46.67% |
| 2022 | -0.15 CAD | 48.28% |
| 2021 | -0.29 CAD | 3.33% |
| 2020 | -0.30 CAD | -100.0% |
| 2019 | -0.15 CAD | -747.46% |
| 2018 | -0.02 CAD | -17600.0% |
| 2017 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CAD | 38.19% |
| 2024 Q1 | -0.01 CAD | 43.53% |
| 2023 Q1 | -0.02 CAD | 89.14% |
| 2023 Q4 | -0.03 CAD | -79.58% |
| 2023 FY | - CAD | 46.67% |
| 2023 Q2 | -0.02 CAD | -57.89% |
| 2023 Q3 | -0.01 CAD | 40.83% |
| 2022 Q2 | -0.01 CAD | 51.84% |
| 2022 FY | - CAD | 48.28% |
| 2022 Q4 | -0.14 CAD | -334.78% |
| 2022 Q1 | -0.03 CAD | 75.27% |
| 2022 Q3 | -0.03 CAD | -145.8% |
| 2021 Q2 | -0.06 CAD | 25.27% |
| 2021 Q1 | -0.08 CAD | -90.95% |
| 2021 Q3 | -0.04 CAD | 41.46% |
| 2021 Q4 | -0.11 CAD | -205.56% |
| 2021 FY | - CAD | 3.33% |
| 2020 Q4 | -0.04 CAD | 60.82% |
| 2020 Q2 | -0.06 CAD | 9.85% |
| 2020 Q1 | -0.07 CAD | -60.14% |
| 2020 FY | - CAD | -100.0% |
| 2020 Q3 | -0.11 CAD | -71.61% |
| 2019 Q4 | -0.04 CAD | 43.58% |
| 2019 FY | - CAD | -747.46% |
| 2019 Q3 | -0.08 CAD | -119.22% |
| 2019 Q2 | -0.04 CAD | -99.44% |
| 2019 Q1 | -0.02 CAD | -74.76% |
| 2018 Q1 | -0.00 CAD | 0.0% |
| 2018 Q2 | -0.01 CAD | -235.29% |
| 2018 FY | - CAD | -17600.0% |
| 2018 Q4 | -0.01 CAD | -505.88% |
| 2018 Q3 | -0.00 CAD | 70.18% |
| 2017 FY | - CAD | 0.0% |